Acute Conjunctivitis Treatment Market: By Type (Viral Conjunctivitis, Bacterial Conjunctivitis, Allergic Conjunctivitis, Conjunctivitis Caused by Irritants), By Dosage Form (Gels and Cream, Eye drops, Tablets and Capsules), By Drug Class (Antihistamines, Antibiotic, Mast cell stabilizers, Anti-inflammatory drugs, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Acute Conjunctivitis Treatment Market was valued at USD 4.8 billion in 2022 and is anticipated to grow at USD 6.5 billion by 2029 recording a CAGR of 4.0% from the forecast period 2023-2029. Acute Conjunctivitis Treatment Market report gives a comprehensive outlook on global market scenario, growth trends, shares, with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The report on the global Acute Conjunctivitis Treatment market gives historical, current, and future market sizes (US$ Mn) on the basis of type, dosage form, drug class, distribution channel and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyze the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include manufacturers, distributors, policy makers, and service providers engaged in Acute Conjunctivitis Treatment. Conjunctivitis, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Conjunctivitis can be highly communicable and can be spread easily by contact with secretions of eye from the infected person. Symptoms includes tearing, itching and redness of the eyes. It can also lead to discharge or crusting around the eyes. It's important to stop wearing contact lenses whilst affected by conjunctivitis. Conjunctivitis often resolves on its own, but treatment can speed up the recovery process. Allergic conjunctivitis can be treated with antihistamines. Bacterial conjunctivitis can be treated with antibiotic eye drops.

The Conjunctivitis Treatment Market Key Developments : 
  • In June 2017, Teva Pharmaceuticals launched, generic version of Pataday (olopatadine hydrochloride ophthalmic solution) 0.2%, in U.S used to treat Allergic conjunctivitis
  • In February 2015, Novartis division, Alcon has received USFDA approval for Pazeo(TM) (olopatadine hydrochloride ophthalmic solution) 0.7%, to treat ocular itching which is associated with allergic conjunctivitis.

Global Acute Conjunctivitis Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4%

Largest Market

North America

Fastest Growing Market

Europe
Acute Conjunctivitis Treatment Market Dynamics

Acute conjunctivitis treatment market is because of increasing aging of the population, increase in ophthalmic diseases prevalence rate, rise in investments for the development of new products, growing conscious towards health, funded eye check-up campaigns by governments of different countries are driving the growth of acute conjunctivitis treatment market. Moreover, increasing awareness about various eye infections and rise in blindness prevalence among geriatric population boosting the market growth of acute conjunctivitis treatment. However, due to the stringent regulations in drugs developmental process and side effects associated with the various antibiotics would hamper the adoption of eye infection pharmaceutical treatment, in turn, hinder the market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Acute Conjunctivitis Treatment Market Segmentation

By Type
By Dosage Form
  • Gels and Cream
  • Eye drops
  • Tablets and Capsules
By Drug Class
  • Antihistamines
  • Antibiotic
  • Mast cell stabilizers
  • Anti-inflammatory drugs
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Acute Conjunctivitis Treatment Market was valued at USD 4.8 billion in 2022 and is anticipated to grow at USD 6.5 billion by 2029 recording a CAGR of 4.0% from the forecast period 2023-2029.

The Acute Conjunctivitis Treatment Market is witnessing a steady growth trend, fueled by the rising incidence of eye infections, increased healthcare awareness, and the development of innovative therapies.

The Acute Conjunctivitis Treatment Market faces threats from the increasing availability of over-the-counter eye drops and the potential for antibiotic resistance in cases of bacterial conjunctivitis.

1.Executive Summary
2.Global Acute Conjunctivitis Treatment Market Introduction 
2.1.Global Acute Conjunctivitis Treatment Market  - Taxonomy
2.2.Global Acute Conjunctivitis Treatment Market  - Definitions
2.2.1.Type
2.2.2.Dosage Form
2.2.3.Drug Class
2.2.4.Distribution Channel
2.2.5.Region
3.Global Acute Conjunctivitis Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Acute Conjunctivitis Treatment Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Acute Conjunctivitis Treatment Market  By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Viral Conjunctivitis
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Bacterial Conjunctivitis
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Allergic Conjunctivitis
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Conjunctivitis Caused by Irritants
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Acute Conjunctivitis Treatment Market  By Dosage Form, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Gels and Cream
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Eye drops
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Tablets and Capsules
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Acute Conjunctivitis Treatment Market  By Drug Class, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Antihistamines
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Antibiotic
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Mast cell stabilizers
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Anti-inflammatory drugs
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Acute Conjunctivitis Treatment Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Acute Conjunctivitis Treatment Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Acute Conjunctivitis Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Viral Conjunctivitis
10.1.2.Bacterial Conjunctivitis
10.1.3.Allergic Conjunctivitis
10.1.4.Conjunctivitis Caused by Irritants
10.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Gels and Cream
10.2.2.Eye drops
10.2.3.Tablets and Capsules
10.3.  Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Antihistamines
10.3.2.Antibiotic
10.3.3.Mast cell stabilizers
10.3.4.Anti-inflammatory drugs
10.3.5.Others
10.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies
10.4.2.Retail Pharmacies
10.4.3.Online Pharmacies
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Acute Conjunctivitis Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Viral Conjunctivitis
11.1.2.Bacterial Conjunctivitis
11.1.3.Allergic Conjunctivitis
11.1.4.Conjunctivitis Caused by Irritants
11.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Gels and Cream
11.2.2.Eye drops
11.2.3.Tablets and Capsules
11.3.  Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Antihistamines
11.3.2.Antibiotic
11.3.3.Mast cell stabilizers
11.3.4.Anti-inflammatory drugs
11.3.5.Others
11.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies
11.4.2.Retail Pharmacies
11.4.3.Online Pharmacies
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12.Asia Pacific (APAC) Acute Conjunctivitis Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Viral Conjunctivitis
12.1.2.Bacterial Conjunctivitis
12.1.3.Allergic Conjunctivitis
12.1.4.Conjunctivitis Caused by Irritants
12.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Gels and Cream
12.2.2.Eye drops
12.2.3.Tablets and Capsules
12.3.  Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Antihistamines
12.3.2.Antibiotic
12.3.3.Mast cell stabilizers
12.3.4.Anti-inflammatory drugs
12.3.5.Others
12.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies
12.4.2.Retail Pharmacies
12.4.3.Online Pharmacies
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Acute Conjunctivitis Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Viral Conjunctivitis
13.1.2.Bacterial Conjunctivitis
13.1.3.Allergic Conjunctivitis
13.1.4.Conjunctivitis Caused by Irritants
13.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Gels and Cream
13.2.2.Eye drops
13.2.3.Tablets and Capsules
13.3.  Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Antihistamines
13.3.2.Antibiotic
13.3.3.Mast cell stabilizers
13.3.4.Anti-inflammatory drugs
13.3.5.Others
13.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies
13.4.2.Retail Pharmacies
13.4.3.Online Pharmacies
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Acute Conjunctivitis Treatment Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Viral Conjunctivitis
14.1.2.Bacterial Conjunctivitis
14.1.3.Allergic Conjunctivitis
14.1.4.Conjunctivitis Caused by Irritants
14.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Gels and Cream
14.2.2.Eye drops
14.2.3.Tablets and Capsules
14.3.  Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Antihistamines
14.3.2.Antibiotic
14.3.3.Mast cell stabilizers
14.3.4.Anti-inflammatory drugs
14.3.5.Others
14.4.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies
14.4.2.Retail Pharmacies
14.4.3.Online Pharmacies
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Pfizer, Inc. (U.S)
15.2.2.Allergan Inc. (Ireland)
15.2.3.Boehringer Ingelheim GmbH (Germany)
15.2.4.CIBA Vision Ophthalmics (U.S)
15.2.5.Sanofi (France)
15.2.6.Novartis AG (Switzerland)
15.2.7.Bausch & Lomb Inc. (Valeant) (Canada)
15.2.8.Merck & Co., Inc. (U.S)
15.2.9.Santen Pharmaceuticals Co. Ltd.(Japan)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Pfizer, Inc. (U.S)
  • Allergan Inc. (Ireland)
  • Boehringer Ingelheim GmbH (Germany)
  • CIBA Vision Ophthalmics (U.S)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Bausch & Lomb Inc. (Valeant) (Canada)
  • Merck & Co., Inc. (U.S)
  • Santen Pharmaceuticals Co. Ltd.(Japan)

Adjacent Markets